Concentriq Dx— 510(k) K230839
Substantially EquivalentProscia, Inc.
FDA 510(k) clearance K230839 for Concentriq Dx, Substantially Equivalent on 2024-02-08. Applicant: Proscia, Inc..
Clearance details
- Applicant
- Proscia, Inc.
- Product code
- Code PSY
- Advisory panel
- Pathology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Philadelphia, PA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.